Bone Wax Market - By Product (Absorbable, Non-absorbable), Material (Natural, Synthetic), Application (Neurosurgery, Orthopedic Surgery, Thoracic Surgery, Dental/Oral Surgery), End-use (Hospitals, Specialty Clinics, ASC’s) & Forecast, 2024 – 2032
Published on: 2024-07-20 | No of Pages : 240 | Industry : Healthcare
Publisher : MIR | Format : PDF&Excel
Bone Wax Market - By Product (Absorbable, Non-absorbable), Material (Natural, Synthetic), Application (Neurosurgery, Orthopedic Surgery, Thoracic Surgery, Dental/Oral Surgery), End-use (Hospitals, Specialty Clinics, ASC’s) & Forecast, 2024 – 2032
Bone Wax Market Size
Bone Wax Market was valued at around USD 53 million in 2023 and is estimated to register a CAGR of over 3.1% between 2024 and 2032. Bone wax is used in surgical procedures to control bleeding from bone surfaces. It is a waxy substance made from a mixture of beeswax and other substances, such as petroleum jelly or paraffin wax. The wax acts as a hemostatic agent, creating a physical barrier to blood flow and promoting clotting at the site of application. The increasing cases of bone fracture across the globe is a significant driver for the market.
For instance, according to the Osteoporosis Canada Facts and Stats, in 2022, one in three women and one in five men experienced an osteoporotic fracture in their lifetime. Similarly, according to the International Osteoporosis Foundation, every year, more than 8.9 million fractures occur globally due to osteoporosis. This means that an osteoporosis fracture happens every three seconds. The rising number of fractures leads to a higher demand for bone wax in surgical procedures.
Report Attribute | Details |
---|---|
Base Year | 2023 |
Bone Wax Market Size in 2023 | USD 53 Million |
Forecast Period | 2024 - 2032 |
Forecast Period 2024 - 2032 CAGR | 3.1% |
2032 Value Projection | USD 69.3 Million |
Historical Data for | 2018 – 2023 |
No. of Pages | 160 |
Tables, Charts & Figures | 272 |
Segments covered | Product, Material, Application, End-use, and Region |
Growth Drivers |
|
Pitfalls & Challenges |
|
Furthermore, market growth is attributed to multiple factors, including the rising prevalence of orthopedic disorders, advancements in surgical techniques, increasing bone & joint health supplements market, which is estimated to reach 26.4 billion by 2032, surging bone replacement market, and increasing government initiatives and funding.
Bone Wax Market Trends
Market growth is predicted to be driven by the rising prevalence of orthopaedic disorders. Various disorders including joint degeneration, spinal disorders, bone tumours, trauma cases, and degenerative bone diseases uses bone wax as a haemostatic agent to control bleeding from bone surfaces.
- For instance, according to the Institute for Health Metrics and Evaluation, in 2023, approximately 15% of individuals aged 30 and older experience osteoarthritis. It's projected that nearly 1 billion people will be living with osteoarthritis, the most common form of arthritis, by 2050.
- Conditions such as rheumatoid arthritis and avascular necrosis frequently lead to joint degeneration, necessitating joint replacement surgeries. These procedures involve removing damaged bone and inserting artificial joints. Bone wax plays a critical role in controlling bleeding during bone preparation and implantation, making it indispensable in joint replacement surgeries.
- Additionally, orthopedic trauma resulting from accidents, falls, sports injuries, or violence often requires bone wax to achieve hemostasis and stabilize fractured bones.
- Thus, advances in orthopedic devices, surgical techniques and equipment have made surgeries more effective and safer and increasing the adoption of bone wax, thereby escalating the growth of the market.
Bone Wax Market Analysis
Based on product, the global bone wax industry is bifurcated into absorbable bone wax and non-absorbable bone wax. The non-absorbable bone wax segment held the market size of USD 36.3 million in 2023.
- Non-absorbable bone wax offers prolonged hemostatic properties compared to absorbable bone wax, making it particularly advantageous in surgeries requiring extended bleeding control.
- Its ease of handling and application allows surgeons to mold it into the desired shape and apply it onto bleeding bone surfaces, where it adheres effectively. This pliable nature facilitates precise application, making it a convenient option for various surgical procedures.
- Furthermore, non-absorbable bone wax effectively seals bleeding bone surfaces, creating a physical barrier to blood flow. This property is essential in orthopedic surgeries, where controlling bleeding from bone edges is critical for optimal surgical outcomes.
- Therefore, these factors are expected to drive the growth of the non-absorbable bone wax segment.
Based on material, the bone wax market is segmented into natural bone wax and synthetic bone wax. The natural bone wax segment is expected reach a market size of USD 42.9 million by 2032.
- Natural bone wax is derived from a mixture of beeswax and is considered highly biocompatible. Being a natural product, it is well-tolerated by the body and does not cause adverse reactions or tissue irritation. This biocompatibility makes natural bone wax a preferred choice among surgeons and healthcare professionals.
- Moreover, it is readily available and relatively cost-effective compared to synthetic alternatives. Hospitals and healthcare facilities can procure natural bone wax easily, making it a convenient choice for routine surgical procedures.
- Unlike some synthetic bone wax materials, natural bone wax does not elicit a significant foreign body reaction. This means that the body's immune response to the wax is minimal reducing the risk of complications and promoting better healing.
- Thus, these factors collectively contribute to its widespread use and continued dominance, thereby driving the segmental growth.
Based on application, the bone wax market is categorised into neurosurgery, orthopedic surgery, thoracic surgery, dental/oral surgery, and other applications. The orthopedic surgery held a market share of 30.4% in 2023.
- Increasing number of fractures contributes to the adoption of bone wax. For instance, as per the International Osteoporosis Foundation, in 2024, up to 37 million fragility fractures occur annually in individuals aged over 55, the equivalent of 70 fractures per minute worldwide.
- Orthopedic surgery encompasses a broad range of procedures, from simple fracture repairs to complex joint replacements and spinal surgeries. Many of these procedures involve bone wax as a crucial component to control bleeding and promote recovery.
- Further, bone wax is used in hip and knee replacements during bone preparation and implantation of artificial joints. Consequently, as the population ages and the prevalence of joint degeneration rises, so does the demand for joint replacement surgeries and bone wax.
- Thus, all these factors are expected to escalate the growth of the segment.
Based on end-use, the bone wax market is classified into hospitals, specialty clinics, ambulatory surgical centers, and other end-users. The hospitals segment held a market size of USD 18.9 million in 2023.
- Hospitals house various departments, such as orthopedics, neurosurgery, trauma centers, and oncology units, all of which utilize bone wax in their surgical procedures.
- These settings are adopting various orthopedic programs. For instance, according to the Becker's Hospital report, in 2023, there has been around 100 hospitals with orthopedic across the U.S. Consequently, creating a swift demand of bone wax.
- Additionally, hospitals have the resources and infrastructure necessary to store and utilize bone wax effectively. They maintain adequate supplies of bone wax to meet the demands of their surgical departments, ensuring its availability for various procedures.
- Thus, all these factors are projected to accelerate the growth of the segment.
North America bone wax market accounted for USD 21.5 million in 2023 and is predicted to witness substantial CAGR over the analysis timeline.
- The region's hospitals and surgical centers are well-equipped with the latest surgical instruments and supplies, including bone wax. This advanced infrastructure enables widespread use of bone wax in orthopedic and surgical procedures.
- North America a hub for medical innovation and technological advancements. The companies are at the forefront of developing and manufacturing bone wax. The availability of technologically advanced bone wax products with improved hemostatic properties and biocompatibility drives their adoption in the region.
- Further, according to the Children's Safety Network, each year over 3.5 million children under the age of 15 years require medical treatment for sports-related injuries including bone wax.
- Additionally, North America has strict regulatory standards for bone. Compliance with these standards ensures quality and safety, driving the growth of the market.
Bone Wax Market Share
The bone wax industry is competitive in nature, with several large multinationals and small and mid-sized companies competing in the industry. Companies are developing innovative bone wax for surgeries, replacement, and complex fractures. These bone wax range from natural to synthetic, and from absorbable to non-absorbable. Regulatory approvals and collaborations with research institutions further influence market positioning.
Bone Wax Market Companies
Some of the eminent market participants operating in the bone wax industry include
- Abyrx, Inc
- B. Braun Melsungen AG
- Baxter International Inc.
- Bentley Healthcare Pvt. Ltd.
- Futura Surgicare Pvt Ltd.
- GPC Medical Ltd.
- Johnson & Johnson
- Medline Industries, Inc.
- Medtronic plc
- Wound Management Technologies, Inc.
Bone Wax Industry News
- In September 2023, Abyrx, Inc., announced that the U.S. Food and Drug Administration (FDA) has provided regulatory clearance for the company's MONTAGE Settable Bone Putty for use in cardiothoracic surgery following sternotomy. This enhanced the domain of orthopedic surgeries including bone wax and fillers. Thus, it increased product portfolio of the company and generated sales.
- In April 2022, Medline International B.V., announced a definitive agreement of 100% acquisition of shares of ASID BONZ GmbH. This acquisition strengthened the bone wax portfolio of the company by utilizing the advanced and sophisticated techniques via this agreement. Thus, it expanded the demands and sales of the product, thereby growing the revenue of the company.
Bone wax market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2021 – 2032 for the following segments
Click here to Buy Section of this Report
Market, By Product
- Absorbable bone wax
- Non-absorbable bone wax
Market, By Material
- Natural bone wax
- Synthetic bone wax
Market, By Application
- Neurosurgery
- Orthopedic surgery
- Thoracic surgery
- Dental/Oral surgery
- Other applications
Market, By End-use
- Hospitals
- Specialty clinics
- Ambulatory surgical centers
- Other end-users
The above information is provided for the following regions and countries
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East and Africa
- Saudi Arabia
- South Africa
- UAE
- Rest of Middle East and Africa